Guidance and Reference Materials

OSHA Technical Manual (OTM) | Section III: Chapter 2 - Indoor Air Quality Investigation

Assoc for Professions in Infection Control & Epidemiology. Resources to Assist with COVID-19 Response Need additional IP assistance in your facility? APIC Consulting Services has board-certified consultants ready to assist long-term care facilities with remote surveillance, COVID-19-specific policies for protecting resident & employee health, and COVID-19 prevention staff training. Visit our website for more information.

What is repeated dose toxicity (definition, NOAEL, subacute, subchronic, chronic toxicity), study design and how it is used for hazard classification and risk assessment.

*******{Paying earlier registrants and researchers for ingredient efficacy & safety data studies you cite for your product's application} This chapter provides information about data compensation requirements, procedures, and obligations when submitting an application for registration, amended registration, reregistration or registration review. "For assistance concerning the data compensation procedures, please contact the appropriate Branch for your pesticide product."

Mission, organization and contact information for EPA's Office of Research and Development, which provides scientific foundation for informed decision-making to safeguard human health and ecosystems from environmental pollutants.

******* "EPA may also consider new active ingredients or new uses for currently registered active ingredients (including higher application rates, new application methods such as fogging and electrostatic sprayers, or use sites such as porous surfaces) for expedited review. Please contact the Product Manager assigned to your active ingredient and/or product to discuss the data needs for these types of applications and whether or how such an application can be expedited."

"EPA recently announced that it is expediting its review of requests from registrants pursuant to the Agency’s Emerging Viral Pathogens Guidance for Antimicrobial Pesticides. This guidance provides a pathway for registrants to make claims in off-label communications that their registered disinfectants may be used against viral pathogens like human coronavirus. Once such claims are approved, they can be made for the disinfectant in off-label materials only, such as technical literature distributed to health care facilities, physicians, nurses, or public health officials, non-label-related websites, consumer information services, and on social media sites. Nothing in this expedited review eliminates the need to comply with FIFRA." "EPA typically enforces FIFRA through stop-sale orders and penalty actions authorized under sections 13 and 14"

"EPA is expediting the review of disinfectants eligible for inclusion on List N as well as applications to add directions for use with electrostatic sprayers to products intended to kill SARS-CoV-2."

Ads unreg use

****!!!!*****

EPA Pesticide Registration Notice 2018-1

Includes exemptions & rules under Environmental Protection Agency *Minor Use Program*

Web site describing EPA's compliance assistance centers

Electronic Code of Federal Regulations (eCFR) published by the Government Publishing Office

*******{inc Registration Review Antimicrobials & Pesticide Re-evaluation (RED) Divisions.} Find contacts for PRIA, conventional pesticides, product registration, Registration review, FIFRA 6(a)(2), containers, storage and disposal, data submittters list, child resistant packaging

"EUPs are required for testing of pesticides indoors... This includes testing ...disinfectants under actual use conditions."

Pesticide product labels provide critical information about how to safely and legally handle and use pesticide products. Unlike most other types of product labels, pesticide labels are legally enforceable. Learn about pesticide product labels.

This page explains changes to the data requirements for antimicrobial pesticides and describes the antimicrobial pesticide use site index.

MCM facilitates communication between federal government agencies and public stakeholders to enhance the Nation's public health emergency preparedness.

The U.S. government is providing a portal for the 2019 novel coronavirus (COVID-19) medical countermeasures task force as a single point of entry for the submission of market research packages and meeting requests from interested stakeholders.

FDA is helping to accelerate the development of COVID-19 prevention and treatment options through new guidance for innovators and researchers.

Guidance for Industry and Investigators

Emergency authorization conditions, & lists of company's products authorized so far

Explore EPA's guidance documents as defined in Executive Order 13891.

EPA News Release: EPA Meets President Trump’s Deadline, Makes Agency Guidance Available to the Public

{Does not include Chlorine Dioxide}